Comparison of nasal deposition and clearance of aerosol generated by a nebulizer and an aqueous spray pump

Pharmaceutical Research

Volumn 16, Issue 10, 1999, Pages 1648-1652

  Suman, Julie D ^a   Laube, Beth L ^b   Dalby, Richard ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aerosol deposition; Gamma scintigraphy; Mucociliary clearance; Nasal cavity; Nasal spray; Nebulizer

Indexed keywords

PENTETIC ACID; PERTECHNETIC ACID TC 99M; SODIUM CHLORIDE; XENON 133;

ADULT; AEROSOL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MUCOCILIARY CLEARANCE; NEBULIZER; NORMAL HUMAN; NOSE CAVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AEROSOLS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MUCOCILIARY CLEARANCE; NASAL CAVITY; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; TECHNETIUM COMPOUNDS; XENON RADIOISOTOPES;

EID: 0032754596     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011933410898     Document Type: Article

References (14)

1. A. E. Pontiroli, A. Caldera, and G. Pozza. Intranasal drug delivery-potential advantages and limitations from a clinical pharmacokinetic perspective. Clin. Pharmacokinet. 17(5):299-307 (1989).
2. S. P. Newman, F. Moren, and S. W. Clarke. The nasal distribution of metered dose inhalers. J. Laryngol. Otol. 101:127-132 (1987).
3. J. G. Hardy, S. W. Lee, and C. G Wilson. Intranasal drug delivery by spray and drops. J. Pharm. Pharmacol. 37:294-297 (1985).
4. S. P. Newman, F. Moren, and S. W. Clarke. Deposition pattern of nasal sprays in man. Rhinology 26:111-120 (1988).
5. F. Y. Aoki and J. C. W. Crawley. Distribution and removal of human albumin-technetium 99 m instilled intranasally. J. Pharm. Pharmacol. 3:869-878 (1976).
6. G. Coates, M. Dolovich, D. Koehler, and M. T. Newhouse. Ventilation scanning with technetium labeled aerosols DTPA or sulfur colloid? Clin. Nuc. Med. 10:835-838 (1985).
7. J. D. Suman, B. L. Laube, and R. Dalby. Nasal nebulizers versus aqueous spray pumps: a comparison of deposition patterns in human volunteers. Respiratory Drug Delivery VI, Interpharm Press, Inc. Buffalo Grove, IL. 211-218 (1998).
8. D. J. Macy and R. Marshall. Absolute quantitation of radiotracer uptake in the lungs using a gamma camera. J. Nucl. Med. 23:731-734 (1982).
9. Y. W. Chien, K. S. E. Yu, and S. Chang. Physicochemical, Biopharmaceutical, and Toxicophysiological Considerations. In Nasal Systemic Drug Delivery, Marcek Dekker, Inc., New York, 1989, pp. 39-85.
10. G. Yu, Z. Zhang, and R. Lessman. Fluid flow and particle diffusion in the human upper respiratory system. Aero. Sci. Tech. 28:146-158 (1998).
11. I. Andersen and D. F. Proctor. Measurement of nasal mucociliary clearance. Eur. J. Resp. Dis. 64(S127):37-40 (1983).
12. A. S. Harris, I. M. Nilsson, Z. G. Wagner, and U. Alkner. Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin. J. Pharm. Sci. 75:1085-1088 (1986).
13. N. G. M. Schipper, J. C. Verhoef, and Frans W. H. M. Merkus. The nasal mucociliary clearance: relevance to nasal drug delivery. Pharm. Res. 8:807-814 (1991).
14. N Mygind. Upper airway: structure, function and therapy. In F. Moron, M. B. Dolovich, M. T. Newhouse, and S. P. Newman (eds.), Aerosols in Medicine, Principles, Diagnosis, and Therapy, Elsevier Science Publishers B.V., Amsterdam, 1993, pp. 1-26.